Back
TG Therapeutics Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
60
TGTX
TG Therapeutics
Last Price:
$34.36
Seasonality Move:
2.25%
7 Day Trial
ALL ACCESS PASS
$
7

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
TG Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.01 | Buy |
20-day SMA: | 38.04 | Sell |
50-day SMA: | 38.61 | Sell |
200-day SMA: | 30.23 | Buy |
8-day EMA: | 34.77 | Sell |
20-day EMA: | 36.65 | Sell |
50-day EMA: | 36.98 | Sell |
200-day EMA: | 31.02 | Buy |
TG Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.41 | Sell |
Relative Strength Index (14 RSI): | 40.71 | Sell |
Chaikin Money Flow: | 1356263 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.3 - 41.82) | Sell |
Bollinger Bands (100): | (30.31 - 39.43) | Sell |
TG Therapeutics Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for TG Therapeutics Stock
Is TG Therapeutics Stock a Buy?
-
TG Therapeutics share price is 34.36 while TGTX 8-day simple moving average is 34.01, which is a Buy signal.
-
The stock price of TGTX is 34.36 while TG Therapeutics 20-day SMA is 38.04, which makes it a Sell.
-
TG Therapeutics 50-day simple moving average is 38.61 while TGTX share price is 34.36, making it a Sell technically.
-
TGTX stock price is 34.36 and TG Therapeutics 200-day simple moving average is 30.23, creating a Buy signal.
TGTX Technical Analysis vs Fundamental Analysis
Buy
60
TG Therapeutics (TGTX)
is a Buy
Is TG Therapeutics a Buy or a Sell?
-
TG Therapeutics stock is rated a BuyThe current TG Therapeutics [TGTX] share price is $34.36. The Score for TGTX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
TG Therapeutics Stock Info
Market Cap:
5.5B
Price in USD:
34.36
Share Volume:
1.9M
TG Therapeutics 52-Week Range
52-Week High:
46.48
52-Week Low:
15.16
Buy
60
TG Therapeutics (TGTX)
is a Buy
TG Therapeutics Share Price Forecast
-
What is the TG Therapeutics stock price today?The TG Therapeutics stock price is 34.36 USD today.
-
Will TGTX stock go up or go down?TG Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is TG Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, TG Therapeutics is not overvalued.
Is TG Therapeutics Stock a Buy?
-
TG Therapeutics share price is 34.36 while TGTX 8-day exponential moving average is 34.77, which is a Sell signal.
-
The stock price of TGTX is 34.36 while TG Therapeutics 20-day EMA is 36.65, which makes it a Sell.
-
TG Therapeutics 50-day exponential moving average is 36.98 while TGTX share price is 34.36, making it a Sell technically.
-
TGTX stock price is 34.36 and TG Therapeutics 200-day simple moving average is 31.02, creating a Buy signal.
Fundamental Analysis of TG Therapeutics
Is TG Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.18 per share, an increase this year of $0.77 per share, and an increase next year of $0.85 per share.
Technical Analysis of TG Therapeutics
Should I short TG Therapeutics stock?
-
TGTX Moving Average Covergence Divergence (MACD) indicator is -1.41, suggesting TG Therapeutics is a Sell
-
TG Therapeutics Relative Strength Index (RSI) is 40.71, which suggest TG Therapeutics is oversold
-
The Bollinger Bands (25) for TG Therapeutics is (34.3 - 41.82), which suggest TG Therapeutics is a Sell
-
The Bollinger Bands (100) for TG Therapeutics is (30.31 - 39.43), which suggest TG Therapeutics is a Sell
* TG Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.